Chardan Healthcare Acquisition 2 Corp.’s Merger with Renovacor

Latham & Watkins represented Chardan Healthcare Acquisition 2 Corp. in the transaction.Renovacor, Inc. (Renovacor), an early-stage biotechnology company developing AAV-based gene therapies for devastating cardiovascular and…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now